HighTower Advisors »

Milestone Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Milestone Pharmaceuticals (MIST) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Milestone Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Milestone Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Milestone Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $12k 10k 1.19
2023-06-30 $88k 31k 2.84
2023-03-31 $103k 26k 3.93

More positions owned by HighTower Advisors

Apple (AAPL)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for HighTower Advisors

Top funds holding Milestone Pharmaceuticals

Propel Bio Management
Adage Capital Partners GP
Rtw Investments
Two Sigma Investments
Goldman Sachs Group
Marshall Wace
Millennium Management
Simplify Asset Management
Susquehanna International
Point72 Asset Management
Balyasny Asset Management
Lion Point Capital
Toronto-Dominion Bank
Morgan Stanley
Boxer Capital Management

View all funds holding Milestone Pharmaceuticals